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Abstract
Diabetology & Metabolic Syndrome (D&MS), the official journal of the Brazilian Diabetes Society
(SBD), is a new open access, peer reviewed journal publishing research on all aspects of the
pathophysiology of diabetes and metabolic syndrome. With the many ongoing and upcoming
challenges for diabetes diagnosis, treatment and care, a dedicated journal providing unrestricted
access for researchers and health care professionals working in the field of diabetes is needed.
Diabetology & Metabolic Syndrome aims to fulfil this need.
Editorial
Among the many good reasons to launch a new open
access journal devoted to publishing articles in the field of
diabetes research is the fact diabetes is seen as a pandemic
condition of unprecedented proportions. In 2007 there
were an estimated 246 million cases of diabetes world-
wide, with the Western Pacific and the European regions
having the highest numbers, approximately 67 and 53
million, respectively. The prevalence of diabetes is pro-
jected to rise in both developed and developing countries.
In the seven regions of the International Diabetes Federa-
tion (IDF) the estimated numbers of cases will be 380 mil-
lion by 2025. In addition, in many populations, diabetes
is most common among the elderly but prevalence rates
will significantly rise among comparatively young and
productive populations in the developing world [1].
Type 2 diabetes mellitus constitutes about 85% to 95% of
all diabetes cases in developed countries and accounts for
an even higher percentage in developing countries mostly
due to increased urbanization, westernization and eco-
nomic development, which predispose to obesity due to
high consumption of industrialized foods and physical
inactivity [2]. Moreover, because of the inefficiency and
lack of professional and material resources, the public
health systems in developing countries will be facing an
increasing number of people with poorly controlled dia-
betes more predisposed to the devastating microvascular
and macrovascular consequences of the disease.
In addition to the increasing numbers of diabetes cases,
there are many challenges to face in optimising diabetes
care. Highlighting this are studies into the factors, which
can help in predicting the likelihood of achieving glycae-
mic control across various regions of the World. The Inter-
national Diabetes Management Practice Study (IDMPS)
concluded that short disease duration and use of few oral
antidiabetic drugs were predictive factors for achieving
HbA1C <7% in 9,901 T2DM patients recruited by 937
physicians in Eastern Europe, Asia, Latin America, and
Africa [3]. In Asia and South America, absence of microv-
ascular complications was an additional predictor. These
findings suggest that early diagnosis and prompt initia-
tion of insulin therapy in patients treated with multiple
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oral antidiabetic drugs may increase the likelihood of
attaining glycaemic targets. In Asia and South America,
old age was a predictor, which complies with data from
the U.S. Diabetes Prevention Program, showing lifestyle
modification was more effective in elderly rather than
young people, who may be less compliant because of
competing priorities. In Asia, lack of obesity and self-
adjustment of insulin dosages were predictors, emphasiz-
ing the double hit of obesity and βcell insufficiency in
Asian populations. Other region-specific factors relevant
to self-care (e.g., Self-Monitoring of Blood Glucose and
Self-Adjustment of Insulin) and health care systems (e.g.,
health insurance coverage and access to specialists and
diabetes educators) further reflect the multiple challenges
the optimization of diabetes care presents [4].
Another important reason for launching the journal is
related to the controversies regarding the concept of met-
abolic syndrome. The term "metabolic syndrome" refers
to the clustering of a number of cardiovascular risk factors
(obesity, hypertension, dyslipidaemia and hyperglycae-
mia), believed to be related to insulin resistance. In the
eighties Reaven had insulin resistance as the central and
hypothetically causal factor tying the syndrome together
[5]. The more recent definition by International Diabetes
Federation [6] consider obesity or central obesity as the
central factor defining the syndrome if at least other ele-
ments of dyslipidaemia, hypertension and hyperglycae-
mia are present, and where insulin resistance is no longer
even a part of the syndrome. Despite the fact that an
uncountable number of scientific papers on metabolic
syndrome have been published over the last ten years,
there are controversies concerning the definition of the
metabolic syndrome, the diagnostic criteria used to define
it, its aetiology, its usefulness and even its existence [7]. In
general, however, differences of opinion surrounding the
syndrome are minor.
The concept of metabolic syndrome has good points but
it also has weak aspects. For example, the syndrome is an
attempt to capture both cardiovascular disease and T2DM
risks, which are not necessarily the same things [8]. Meta-
bolic syndrome provides a simple diagnostic set for iden-
tifying people in high relative risk to develop
cardiovascular disease but does not provide a measure of
absolute risk. To obtain the absolute risk, it needs to be
used with other risk markers such as smoking, high levels
of LDL-C and a family history of heart disease to give the
'overall cardiometabolic risk'. The definition of metabolic
syndrome needs further refinement and it requires long-
term outcome studies to evaluate the various criteria
definitively [7].
Many aspects related the origin of metabolic syndrome
become cleared by the words of Borch-Johnsen [9] tran-
scribed here:
"Europe and North America have experienced a gradual
modification of lifestyle over several centuries, where a diet
based on high intake of carbohydrate replaced the tradi-
tional hunter-gatherer diet with high protein intake. Simi-
lar changes have occurred in third world countries, but in
many cases the transition has taken place over decades –
not centuries. A combination of increased access to food and
decreasing demands with respect to physical activity has led
to increasing prevalence of obesity, dyslipidaemia, hyper-
tension and hyperglycaemia/diabetes, a combination of fea-
tures often referred to as the metabolic syndrome."
By 2025, three out of four people with diabetes will be liv-
ing in third world countries, and similar trends are likely
for the other components of the syndrome. Simpler and
low-cost preventive measures are urgently needed to take
place everywhere [9]. A study planned and conducted in
China showed that lifestyle modifications, like physical
activity and healthier diet, were effective in preventing
diabetes [10]. The study was subsequently repeated in Fin-
land, USA, Canada and India, and all these studies con-
firmed the original results. Based on the experiences from
China and India it ought to be possible to develop preven-
tion programmes and strategies that are not only effective,
but also locally acceptable and feasible [9].
D&MS targets a readership comprising clinicians, scien-
tists, paramedical personnel, nutritionists, and health care
personnel working in the field of diabetes. Original
research work and reviews of interest to the above group
of readers will be considered for publication in the jour-
nal.
The Brazilian Diabetes Society is intended to be a nation-
ally and internationally recognized as a reference institu-
tion and diabetes knowledge centre leaning on ethical,
medical, social, and transparency principles independent
of any personal, financial, and corporate interests. The
SBD comprises health care professionals from all over Bra-
zil and abroad in large numbers.
As an open access journal, D&MS not only gives world-
wide visibility to SBD and its activities but also offer a nat-
ural place for publishing the proceedings and abstracts of
the SBD's scientific meetings as supplements. In this way,
the journal can act as a communication forum for issues
of importance to the relevant community, far beyond the
SBD's current membership, and can potentially attract fur-
ther members. In short, having an open access journal is
an excellent way for a professional society like SBD to ful-
fil its mission of furthering knowledge in its field.
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